| Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) JB Buse, J Rosenstock, G Sesti, WE Schmidt, E Montanya, JH Brett, ... The Lancet 374 (9683), 39-47, 2009 | 1967 | 2009 |
| Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial RE Pratley, M Nauck, T Bailey, E Montanya, R Cuddihy, S Filetti, ... The Lancet 375 (9724), 1447-1456, 2010 | 768 | 2010 |
| Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. DA Ehrmann, J Sturis, MM Byrne, T Karrison, RL Rosenfield, KS Polonsky The Journal of clinical investigation 96 (1), 520-527, 1995 | 618 | 1995 |
| Semaglutide and cardiovascular outcomes in obesity without diabetes AM Lincoff, K Brown-Frandsen, HM Colhoun, J Deanfield, SS Emerson, ... New England Journal of Medicine 389 (24), 2221-2232, 2023 | 608 | 2023 |
| Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. MM Byrne, J Sturis, K Clement, N Vionnet, ME Pueyo, M Stoffel, J Takeda, ... The Journal of clinical investigation 93 (3), 1120-1130, 1994 | 395 | 1994 |
| Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12 MM Byrne, J Sturis, S Menzel, K Yamagata, SS Fajans, MJ Dronsfield, ... Diabetes 45 (11), 1503-1510, 1996 | 373 | 1996 |
| Nocturnal exercise phase delays circadian rhythms of melatonin and thyrotropin secretion in normal men O Van Reeth, J Sturis, MM Byrne, JD Blackman, M L'Hermite-Balériaux, ... American Journal of Physiology-Endocrinology And Metabolism 266 (6), E964-E974, 1994 | 330 | 1994 |
| Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. MK Cavaghan, DA Ehrmann, MM Byrne, KS Polonsky The Journal of clinical investigation 100 (3), 530-537, 1997 | 266 | 1997 |
| Demonstration of rapid light-induced advances and delays of the human circadian clock using hormonal phase markers E Van Cauter, J Sturis, MM Byrne, JD Blackman, R Leproult, G Ofek, ... American Journal of Physiology-Endocrinology and Metabolism 266 (6), E953-E963, 1994 | 202 | 1994 |
| Relationships between sleep quality and glucose regulation in normal humans AJ Scheen, MM Byrne, L Plat, R Leproult, E Van Cauter American Journal of Physiology-Endocrinology And Metabolism 271 (2), E261-E270, 1996 | 193 | 1996 |
| Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20 MM Byrne, J Sturis, SS Fajans, FJ Ortiz, A Stoltz, M Stoffel, MJ Smith, ... Diabetes 44 (6), 699-704, 1995 | 178 | 1995 |
| Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans L Plat, MM Byrne, J Sturis, KS Polonsky, J Mockel, F Fery, E Van Cauter American Journal of Physiology-Endocrinology and Metabolism 270 (1), E36-E42, 1996 | 177 | 1996 |
| Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu (UUR) gene mutation G Velho, MM Byrne, K Clément, J Sturis, ME Pueyo, H Blanché, N Vionnet, ... Diabetes 45 (4), 478-487, 1996 | 144 | 1996 |
| Sleepiness, performance, and neuroendocrine function during sleep deprivation: effects of exposure to bright light or exercise R Leproult, O Van Reeth, MM Byrne, J Sturis, E Van Cauter Journal of biological rhythms 12 (3), 245-258, 1997 | 134 | 1997 |
| Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function MM Byrne, J Sturis, RJ Sobel, KS Polonsky American Journal of Physiology-Endocrinology and Metabolism 270 (4), E572-E579, 1996 | 123 | 1996 |
| Insulin secretion and clearance during low-dose graded glucose infusion MM Byrne, J Sturis, KS Polonsky American Journal of Physiology-Endocrinology and Metabolism 268 (1), E21-E27, 1995 | 123 | 1995 |
| Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A–MODY cohort S Bacon, MP Kyithar, SR Rizvi, E Donnelly, A McCarthy, M Burke, ... Diabetic medicine 33 (7), 976-984, 2016 | 99 | 2016 |
| Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity EV Van Cauter, KS Polonsky, JD Blackman, D Roland, J Sturis, MM Byrne, ... The Journal of Clinical Endocrinology & Metabolism 79 (6), 1797-1805, 1994 | 84 | 1994 |
| Glucagon-like peptide 1 improves the ability of the β-cell to sense and respond to glucose in subjects with impaired glucose tolerance MM Byrne, K Gliem, U Wank, R Arnold, M Katschinski, KS Polonsky, ... Diabetes 47 (8), 1259-1265, 1998 | 77 | 1998 |
| Dominant-negative suppression of HNF-1α results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell … H Wobser, H Dußmann, D Kögel, H Wang, C Reimertz, CB Wollheim, ... Journal of Biological Chemistry 277 (8), 6413-6421, 2002 | 76 | 2002 |
